BORKOWSKI EDWARD 4
4 · AzurRx BioPharma, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
BORKOWSKI EDWARD
Director
Transactions
- Award
Common Stock
2020-03-10$4.74/sh+1,319$6,252→ 403,443 total - Award
Common Stock
2020-03-10$0.60/sh+14,584$8,750→ 393,710 total - Award
Common Stock
2020-03-10$1.04/sh+8,414$8,751→ 402,124 total - Award
Common Stock
2020-03-10$4.74/sh+6,330$30,004→ 409,773 total
Holdings
- 13,680(indirect: By Spouse)
Common Stock
Footnotes (8)
- [F1]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2019.
- [F2]Based on the stock price at September 30, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F3]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019.
- [F4]Based on the stock price at December 31, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F5]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2016.
- [F6]Based on the stock price at December 31, 2016, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F7]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors during 2016.
- [F8]Based on the stock price at April 21, 2017, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.